Thomson Medical Group Ltd. · SGX:A50
Thomson Medical — H1 2025 Earnings Presentation
19 slides from Thomson Medical's earnings presentation, Feb 17, 2025
Slide 1: Thomson Medical Group Limited 1H FY2025 Results Briefing
Confidential THOMSON MEDICAL GROUP LIMITED 1H FY2025 Results Briefing 17 February 2025
Slide 2: Disclaimer
Confidential Disclaimer ANNOUNCEMENT SHALL NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES OR ELSEWHERE. For the purposes of this disclaimer, this presentation (“Presentation”) shall mean and include the slides herei
Slide 3: Agenda
Confidential 1 Group Overview 2 1H FY2025 Financial Highlights 3 Key Operational Statistics 4 Future Growth Plans 3
Slide 4: Group Overview
1 Group Overview Confidential 4
Slide 5: Key Businesses
Confidential Key Businesses 100% ▪ One of the largest private providers of healthcare services for women and children in Singapore ▪ 37 clinics and centres today compared to 16 in 2010 S$98m 1H25 Revenue ▪ Multi-disciplinary healthcare company listed on Bursa Malaysia ~70% ▪ Operates Thomson Hospita
Slide 6: Thomson Medical Pte Ltd (TMPL)
Confidential Thomson Medical Pte Ltd (“TMPL”) Singapore Hospital Operations & Ancillary Services 187 37 licensed beds(1) clinics & centres Established in 1979, TMPL owns and operates Thomson Medical Centre (“TMC”) and a network of specialist medical clinics and facilities providing outpatient women
Slide 7: TMC Life Sciences Berhad (TMCLS)
Confidential TMC Life Sciences Berhad (“TMCLS”) Malaysia Hospital Operations & Ancillary Services 373 licensed beds(1)(2) 5 fertility centres In 2008, TMCLS established Thomson Hospital Kota Damansara (“THKD”). THKD is its flagship multi-disciplinary tertiary care centre equipped with advanced medic
Slide 8: Far East Medical Vietnam Limited (FEMVN)
Confidential Far East Medical Vietnam Limited (“FEMVN”) Hospital Operations & Ancillary Services Vietnam In 2008, FEMVN established Franco-Vietnamese Hospital (“FV Hospital”). As the first JCI accredited hospital in South Vietnam, FV Hospital is known for its international standard of care, commitme
Slide 9: 1H FY2025 Financial Highlights
2 1H FY2025 Financial Highlights Confidential 9
Slide 10: Group Financial Highlights – 1H FY2025
Confidential Group Financial Highlights – 1H FY2025 Profitability Financial Position Cash Flows 18.3% increase in Revenue from Cash position of Interest expenses of $168.2m in 1HFY2024 to $169.5m $30.9m $199.1m in 1HFY2025 Debt of $1.1b Net cash outflow of 1.9% increase in EBITDA from $28.1m $38.4m
Slide 11: Historical Financial Highlights
Confidential Historical Financial Highlights REVENUE ($mil) EBITDA ($mil) YoY 18.4% YoY 199.1 1.8% 0.2 168.2 0.2 38.4 39.1 51.9 54.2 YoY 8.9% 16.1 49.4 YoY 10.7 59.0% 21.9 9.0 6.6 YoY YoY 13.6% 6.3% 97.6 19.8 22.5 91.8 YoY (0.7) (6.5) 89.2% 1H FY24 1H FY25 1H FY24 1H FY25 11
Slide 12: Geographical Segments – 1H FY2025
Confidential Geographical Segments – 1H FY2025 Revenue EBITDA (S$ in millions) (S$ in millions) $0.2m $0.2m -$0.7m -$6.5m $10.7m $51.9m $19.8m -2% -17% $91.8m 26% 27% 32% 52% $54.2m 1H FY2024 1H FY2024 55% 1H FY2025 42% 1H FY2025 $168.2m $199.1m 49% $16.1m $38.4m $39.1m $22.5m $97.6m 58% 13% 25% 17%
Slide 13: Key Operational Statistics
3 Key Operational Statistics Confidential 13
Slide 14: Key Operating Statistics
Confidential Key Operating Statistics FY2021 FY2022 FY2023 FY2024 1H 2024 1H 2025 LICENSED BEDS1 Singapore 187 187 187 187 187 187 Malaysia 205 308 350 373 350 373 Vietnam - - - 2304 230 230 Total 392 495 537 790 767 790 OPERATIONAL BEDS2 Singapore 181 181 178 178 178 178 Malaysia 170 299 314 341 33
Slide 15: Key Operating Statistics
Confidential Key Operating Statistics FY2021 FY2022 FY2023 FY2024 1H 2024 \ 1H 2025 NUMBER OF INPATIENT Singapore 20,402 20,972 20,315 17,601 9,221 9,236 Malaysia 18,806 23,107 29,390 31,052 16,246 15,241 Vietnam2 N.A. N.A. N.A. 7,3233 4,023 3,519 Total 39,208 44,079 49,705 55,976 29,490 24,145 NUMB
Slide 16: Key Leverage Ratios
Confidential Key Leverage Ratios S$’m Jun 2022 Jun 2023 Dec 2023 Jun 2024 Dec 2024 Total Debts 629.1 747.8 1,106.9 1,106.2 1,099.4 Cash (161.6) (286.6) (271.9) (167.3) (139.5) Net Debts 467.5 461.2 835.0 947.5 960.0 Equity 608.3 575.4 563.3 576.8 589.5 EBITDA 109.7 103.3 38.4 101.9 39.1 Net Debts /
Slide 17: Future Growth Plans
4 Future Growth Plans Confidential 17
Slide 18: TMG Going Forward: Building for Long-Term Growth
Confidential TMG Going Forward: Building for Long-Term Growth • Strategic high-value healthcare markets high demand for premium healthcare services. • Markets offering high growth potential, capitalizing the Group’s established presence and expertise in Regional Singapore, Malaysia and Vietnam. Expa
Slide 19: Thank You!
THANK YOU! Thomson Medical Group Limited 101 Thomson Road #20-04/05 United Square Singapore 307591 Confidential 19
Thomson Medical Group — H1 2025 Earnings Presentation on 6ix